Hyphema Post Intravitreal Injection of Bevacizumab

Objective: To describe a case of total hyphema after intravitreal injection of Bevacizumab.
Results: This is a 54 years old patient diagnosed with exudative age-related macular degeneration who was admitted for injection of Bevacizumab in the right eye. The visual acuity was 02/10 in both eyes, and the injection was performed after eliminating the contraindications on biomicroscope examination. The immediate evolution after injection was marked by a total hyphema. The management was based on antibiotic and anti-inflammatory eye drops, rehydration and monitoring. The hyphema disappeared after ten days with visual acuity remained at 02/10.